4 September 2017 - PHARMAC is pleased to announce the approval of an agreement with GSK for the supply of its Habitrol brand of nicotine replacement therapy gum, lozenges and patches.

This was the subject of a consultation letter dated 21 July 2017.

Following consultation feedback there were two additions, for clarification, to the way in which the new small pack sizes will be listed in the Pharmaceutical Schedule. It will be made clear in the Schedule that these pack sizes are funded for distribution by Authorised Providers only. In all other aspects, the proposal was approved as consulted on.

Read PHARMAC press release